BruceJDezubeMD

Physician

Dr. Dezube is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
330 Brookline Avenue
Beth Israel Hospital
Boston, MA 02215
Phone+1 617-632-9258

Beth Israel Deaconess Medical CenterFellowship, Hematology and Medical Oncology, 1986 - 1991
Tufts Medical CenterResidency, Internal Medicine, 1983 - 1986
Tufts University School of MedicineClass of 1983

PubMed

341 citations
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Panagiotis A. Konstantinopoulos, Steven E. Waggoner, Gregory A. Vidal, Monica M. Mita, John W. Moroney
JAMA Oncology. 2019-08-01
3454 citations
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Eunice L. Kwak, Yung-Jue Bang, D. Ross Camidge, Alice T. Shaw, Benjamin Solomon
The New England Journal of Medicine. 2010-10-28
11 citations
Extracavitary primary effusion lymphoma of the anorectum.
Liron Pantanowitz, Zhao Wu, Bruce J. Dezube, German Pihan
Clinical Lymphoma & Myeloma. 2005-09-01

Other

Pulmonary involvement in AIDS-related Kaposi sarcoma
Dezube BJ, King TE
http://www.uptodate.com/contents/pulmonary-involvement-in-aids-related-kaposi-sarcoma
UpToDate, Wolters Kluwer Health - 2012-11-02
Psychogenic purpura (Gardner-Diamond syndrome)
Dezube BJ, Geisler BP
http://www.uptodate.com/contents/psychogenic-purpura-gardner-diamond-syndrome
UpToDate, Wolters Kluwer Health - 2012-02-28

Clinical Trial Underscores Promise of Immunotherapy, in Combination with Second Drug, for Ovarian CancerJuly 13th, 2019

Novel Immunomodulator A-007 Of Human Pappilomavirus Infection: A Phase II StudyNational Center For Research Resources2007
Novel Immunomodulator A-007 Of Human Papillomavirus Infection: A Phase II StudyNational Center For Research Resources2006
Beth Israel Deaconess Medical CenterNational Cancer Institute2006
Phase I Trial Of Pehrg214 In Patients With HIV InfectionNational Center For Research Resources2004–2005
Oral Biology Of The Ks-Associated Herpes VirusNational Center For Research Resources2004–2005
Phase I Trial Of Col 3 In HIV Related Kaposi'S SarcomaNational Center For Research Resources2000–2002
Trial Of Hnm01 In Patients With HIV InfectionNational Center For Research Resources1999–2002
Potential Interactions Between Paclitaxel &Protease Inhibitors In KSNational Center For Research Resources1999–2002
Interaction Between S 1153 &Nelfinavir &Indinavir In HIVNational Center For Research Resources1999–2002
Phase I Trial Of S-1153 In Patients With HIV InfectionNational Center For Research Resources1997–2000
Phase I Trial Of FP-21399 In Patients With HIV InfectionNational Center For Research Resources1996–1999
Phase I Study Of TNP-470 In The Treatment Of AIDS Associated Kaposi'S SarcomaNational Center For Research Resources1997
Phase I Study Of TNP-470 In The Treatment Of Aids-Associated Kaposi'S SarcomaNational Center For Research Resources1995–1996